Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTORShuling Zhang, Li Zhao, Youfan Feng et al.|Anti-Cancer Drugs|2024Cited by 10
The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemiaJincai Yang, Lanxia Zhou, Jianle Lu et al.|Journal of Cancer Research and Clinical Oncology|2023Cited by 6
The FTO inhibitor Rhein is a promising option for the treatment of multidrug resistance AMLShuling Zhang, Li Zhao, Youfan Feng et al.|Research Square|2024Cited by 0